2 608

Cited 0 times in

Smooth emergence in men undergoing nasal surgery: the effect site concentration of remifentanil for preventing cough after sevoflurane-balanced anaesthesia

DC Field Value Language
dc.contributor.author박윤곤-
dc.contributor.author이정림-
dc.contributor.author최승호-
dc.date.accessioned2014-12-19T16:20:37Z-
dc.date.available2014-12-19T16:20:37Z-
dc.date.issued2012-
dc.identifier.issn0001-5172-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/89350-
dc.description.abstractBACKGROUND: Suppression of cough during emergence after nasal surgery is practical to avoid bleeding from the surgical site. Previously recommended effect-site concentration of remifentanil for preventing cough during emergence is restricted to female patients undergoing thyroid surgery, so we evaluated effective effect-site concentration of remifentanil for preventing cough during emergence for men undergoing nasal surgery. METHODS: Twenty-four American Society of Anesthesiologists (ASA) physical status I or II, between the ages of 18 and 60 years old, non-smoker male patients undergoing nasal surgery were enrolled in this study. The effective effect-site concentration for 50% of patients (EC(50) ) and and that for 95% of patients (EC(95) ) of remifentanil for preventing cough were determined by Dixon's up-and-down method and by isotonic regression method with a bootstrapping approach. Haemodynamic variables were compared in patients with cough and without cough during emergence. RESULTS: The EC(50) of remifentanil for preventing cough during emergence by Dixon's method was 2.17 ng/ml [standard deviation (SD) 0.38]. The estimated EC(50) and EC(95) of remifentanil using isotonic regression model with a bootstrapping approach were 2.35 ng/ml [95% confidence interval (CI) 1.89-2.66] and 2.94 ng/ml (95% CI 2.83-2.97), respectively. Mean arterial pressure and heart rate were significantly higher in patients with cough during emergence. Three out of 13 patients that received more than 2.5 ng/ml of remifentanil experienced a brief episode of bradypnea. CONCLUSIONS: The EC(95) of remifentanil for preventing cough in men after nasal surgery is 2.94 ng/ml. Remifentanil target-controlled infusion with established effect-site concentration could suppress cough in men during emergence from sevoflurane anaesthesia after nasal surgery, though reversible respiratory depression might arise at high effect-site concentration of remifentanil.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfACTA ANAESTHESIOLOGICA SCANDINAVICA-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdolescent-
dc.subject.MESHAdult-
dc.subject.MESHAnesthesia, Inhalation-
dc.subject.MESHAnesthetics, Inhalation/adverse effects*-
dc.subject.MESHBlood Pressure/drug effects-
dc.subject.MESHCough/prevention & control*-
dc.subject.MESHHeart Rate/drug effects-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMethyl Ethers/adverse effects*-
dc.subject.MESHMiddle Aged-
dc.subject.MESHNose/surgery*-
dc.subject.MESHPiperidines/therapeutic use*-
dc.titleSmooth emergence in men undergoing nasal surgery: the effect site concentration of remifentanil for preventing cough after sevoflurane-balanced anaesthesia-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Anesthesiology (마취통증의학)-
dc.contributor.googleauthorE. M. CHOI-
dc.contributor.googleauthorW-K. PARK-
dc.contributor.googleauthorS-H. CHOI-
dc.contributor.googleauthorS. SOH-
dc.contributor.googleauthorJ-R. LEE-
dc.identifier.doi22220983-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01593-
dc.contributor.localIdA03098-
dc.contributor.localIdA04101-
dc.contributor.localIdA01960-
dc.relation.journalcodeJ00006-
dc.identifier.eissn1399-6576-
dc.identifier.pmid22220983-
dc.identifier.urlhttp://onlinelibrary.wiley.com/doi/10.1111/j.1399-6576.2011.02620.x/abstract-
dc.subject.keywordAdolescent-
dc.subject.keywordAdult-
dc.subject.keywordAnesthesia, Inhalation-
dc.subject.keywordAnesthetics, Inhalation/adverse effects*-
dc.subject.keywordBlood Pressure/drug effects-
dc.subject.keywordCough/prevention & control*-
dc.subject.keywordHeart Rate/drug effects-
dc.subject.keywordHumans-
dc.subject.keywordMale-
dc.subject.keywordMethyl Ethers/adverse effects*-
dc.subject.keywordMiddle Aged-
dc.subject.keywordNose/surgery*-
dc.subject.keywordPiperidines/therapeutic use*-
dc.contributor.alternativeNamePark, Wyun Kon-
dc.contributor.alternativeNameLee, Jeong Rim-
dc.contributor.alternativeNameChoi, Seung Ho-
dc.contributor.affiliatedAuthorPark, Wyun Kon-
dc.contributor.affiliatedAuthorLee, Jeong Rim-
dc.contributor.affiliatedAuthorChoi, Seung Ho-
dc.citation.volume56-
dc.citation.number4-
dc.citation.startPage498-
dc.citation.endPage503-
dc.identifier.bibliographicCitationACTA ANAESTHESIOLOGICA SCANDINAVICA, Vol.56(4) : 498-503, 2012-
dc.identifier.rimsid34550-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.